The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.
  • Ticker

RNS




GlaxoSmithKline PLC - GSK Promising data for GSK2857916 at ASH meeting
07:00 12-Dec-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK New data - Shingrix in immune-compromised patients
07:00 06-Dec-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK ViiV starts Phase 3 HIV prevention study in women
07:00 30-Nov-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK ViiV starts Phase 3 longacting HIV treatment study
14:03 27-Nov-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK GSK submit IMPACT data to support Trelegy Ellipta
07:00 23-Nov-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK ViiV Juluca approved in US as first 2-drug regimen
07:00 22-Nov-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK GSK publishes 2018 dividend dates
14:21 21-Nov-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK Trelegy Ellipta EU approval for treatment of COPD
07:00 16-Nov-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK Directorate Change
14:00 08-Nov-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK Directorate Change
14:00 08-Nov-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK US regulatory application for mepolizumab in COPD
15:01 07-Nov-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK BCMA receives FDA Breakthrough Therapy Designation
07:35 02-Nov-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK Superiority of Anoro Ellipta demonstrated for COPD
11:01 01-Nov-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK CDC ACIP makes recommendations for use of Shingrix
17:46 25-Oct-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK 3rd Quarter Results
12:00 25-Oct-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK GSK's Shingrix Receives US FDA Approval
07:00 23-Oct-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK GSK first approval of Shingrix in Canada
18:31 13-Oct-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK Positive IMPACT results for Trelegy in COPD
07:00 20-Sep-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK Trelegy Ellipta: FDA approval in COPD received
07:00 19-Sep-2017  RNS  0.77% View chart
GlaxoSmithKline PLC - GSK Trelegy Ellipta: positive opinion from CHMP Europe
07:00 15-Sep-2017  RNS  0.77% View chart

 Page 1 of 2

| 1 | 2 | Next



RNS - regulatory news service - home


MARKET NEWS – SEARCH FEATURES

Market News is the definitive place to view real-time UK regulatory disclosures.

You will see a clear and comprehensive search, filter and sort features giving users the ability to:

  • Show only Earnings and News announcements - the default search
  • Show all announcements excluding NAVs & FRNs
  • Show all announcement types
  • See up to 500 stories per page
  • See ‘Most read news’ ticker at the top of the page
  • Select stories by Name/code, source, type, index or sector


about rns

 

News Sources

For information about RNS reach and News Announcements, the news sources available within the Market news section.



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds